GoHealth faces a precarious outlook as its business model undergoes a massive strategic retrenchment, evidenced by quarterly revenue plummeting from $389.1 million in 2024Q4 to just $11.9 million by 2026Q1. The company's reliance on speculative ASC 606 contrac...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q2 2026Latest May 18, 2026 | -$2.36+1.7% vs -$2.40 | $12M-29.5% vs $17M |
Q2 2026 Mar 31, 2026 | -$1.03+61.7% vs -$2.69 | $13M-85.7% vs $89M |
Q4 2025 Nov 13, 2025 | -$0.19+90.8% vs -$2.06 | $34M-61.4% vs $89M |
Q3 2025 Aug 7, 2025 | -$1.23+52.7% vs -$2.60 | $94M-18.4% vs $115M |
Company moves forward in a position of strength and stability, focused on continuing to serve existing Medicare consumers and partners Company moves forward in a position of strength and stability, focused on continuing to serve existing Medicare consumers and partners
Benchmark GOCO against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for GoHealth Inc. (GOCO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.31 | $8.94M | -0.02 | -54.71% | -71.06% | -113.5% | — | |
| $0.43 | $76.32M | 32.55 | 15.5% | 2.68% | 7% | — | |
| $0.84 | $26.79M | -2.48 | 4.06% | 5.42% | 3.23% | — | |
| $122.21 | $12.12B | 22.06 | 10.46% | 10.01% | 18.69% | — | |
| $28.51 | $2.65B | -2.34 | 5.04% | -33.44% | -46.01% | — | |
| $28.39 | $6.33B | 55.67 | 59% | -5.51% | -30.03% | — |
GoHealth Inc. (GOCO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
GoHealth Inc. (GOCO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 21, 2026·SEC
Jun 11, 2026·SEC
Jun 8, 2026·SEC
Get notified when GOCO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GoHealth Inc. (GOCO) stock FAQ — growth, dividends, profitability & financials explained
GoHealth Inc. (GOCO) saw revenue decline by 54.7% over the past year.
GoHealth Inc. (GOCO) reported a net loss of $289.9M for fiscal year 2025.
GoHealth Inc. (GOCO) has a return on equity (ROE) of -113.5%. Negative ROE indicates the company is unprofitable.
GoHealth Inc. (GOCO) has a combined ratio of 142.3%. A ratio above 100% means claims and expenses exceed premiums.
